abstract |
ANTI-PD-L1 ANTIBODIES, THEIR PRODUCTION PROCESS, ISOLATED NUCLEIC ACID, VECTOR, HOST CELL, KIT, AND PHARMACEUTICAL COMPOSITION. The present patent application relates to anti-PD-L1 antibodies or antigen-binding fragments thereof, nucleic acid encoding the same, therapeutic compositions thereof, and their use to enhance T cell function to up-regulate immune responses. cell-mediated and for the treatment of dysfunctional T cell disorders, such as tumor immunity, for the treatment of cancer. |